Ignyta - Company & Market Research Reports

Ignyta is an oncology biotechnology company. The company focuses on integrated therapeutic (Rx) and companion diagnostic (Dx) strategies for treating cancer patients. Its Rx is focused on developing molecularly targeted therapies for eradicating residual disease. Its Dx focuses on pairing the product candidates with biomarker-based companion diagnostics that are designed to identify the patients who will benefit from the therapies it develops. The company was founded in 2011 and is headquartered in San Diego, California.

From
From
From
From
From
From
Neuroblastoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 543 Pages
From
From
Thyroid Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 567 Pages
From
Neuroblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • 506 Pages
From
From
From
From
From
Loading Indicator
adroll